Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
A Standard patent application filed on 14 March 2003 credited to Maduskuie, Thomas P.

Details

Application number :

2003220401  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases  

Inventor :

Maduskuie, Thomas P.  

Agent name :

 

Address for service :

 

Filing date :

14 March 2003  

Associated companies :

 

Applicant name :

BRISTOL-MYERS SQUIBB COMPANY  

Applicant address :

P.O. Box 4000, Route 206 and Provinceline Road, Princeton, NJ 08543-4000  

Old name :

 

Original Source :

Go  

Same Inventor

• Hydantoin derivatives as inhibitors of matrix metalloproteinases...
• Succinoylamino lactams as inhibitors of ABeta protein production
• Isoxazoline derivatives as inhibitors of matrix metalloproteinases...
• Lactam metalloprotease inhibitors
• Novel lactam metalloprotease inhibitors